[FeFe] hydrogenases catalyze the reversible reduction of protons to molecular hydrogen (Adams
(1990); Biochim Biophys Acta 1020 (2): 115–145) and are of significant interest for the …

<?xm-replace_text {Heading}?> Abstract The market for protein therapeutics has grown
significantly over the past two decades and the pace of development continues to increase. It is …

The model iron‐sulfur (Fe‐S) protein ferredoxin (Fd) from Synechocystis sp. PCC 6803 has
been simultaneously produced and matured in a cell‐free production system. After 6 h of …

In 2014, the members of the BioPhorum Operations Group (BPOG) produced a 100-page
continued process verification case study, entitled “Continued Process Verification: An Industry …

Understanding the functional consequences of genetic variation, and how it affects complex
human disease and quantitative traits, remains a critical challenge for biomedicine. We …

Genome-wide association studies have identified thousands of loci for common diseases,
but, for the majority of these, the mechanisms underlying disease susceptibility remain …

PURPOSE: To evaluate the efficacy and safety of intravitreal ranibizumab in diabetic
macular edema (DME) patients. DESIGN: Two parallel, methodologically identical, phase III, …

… Boyer MD 4 , Sunil Patel MD, PhD 5 , Leonard Feiner MD, PhD 6 , Patricio G. Schlottmann
MD 7 , Amy Chen Rundle MS 8 , Jiameng Zhang PhD 8 , Roman G. Rubio MD 8 , Anthony P. …

Purpose A head-to-head comparison was performed between vascular endothelial growth
factor blockade and laser for treatment of diabetic macular edema (DME). Design Two …

… Boyer MD 5 , Edoardo Midena MD 6 , Jeffrey S. Heier MD 7 , Hiroko Terasaki MD 8 , Peter
K. Kaiser MD 9 , … Marcus MD 10 , Quan D. Nguyen MD 3 , Glenn J. Jaffe MD 11 , Jason S. …